Biotech 2050 Podcast
130. Breast cancer: targeted treatment options, Sean Bohen, President & CEO, Olema Oncology
about a year ago
129. Progress in complex diseases: NASH, Long COVID, and beyond, Bill Hinshaw, Pres. & CEO, Axcella
about a year ago
128. Treating rare neurological diseases & guiding mission, Jeremy Levin, Chairman & CEO, Ovid Tx
about a year ago
127. Immuno-oncology landscape, Keith Flaherty, Dir. of Clin. Research, Mass General Cancer Center
about a year ago
126. New frontier in biology: harnessing the power of the repeatome, Dennis Zaller, CSO, ROME tx
about a year ago
125. Gene circuits for smarter medicine, Tim Lu, Co-Founder & CEO, & Kanya Rajangam, CMDO, Senti Bio
about a year ago
124. Leukemia and beyond: Next-gen precision cell therapy, Ivan Dimov, Co-Founder & CEO, Orca Bio
about a year ago